Evidence in BRAF-Mutant CRC Tumors

Tanios Bekaii-Saab, MD; Fortunato Ciardiello, MD, PhD; Paul R. Helft, MD; and John L. Marshall, MD, provide an update on BRAF-mutant colorectal cancer clinical trial data, including the SWOG S1406 study with irinotecan plus cetuximab with or without vemurafenib.